Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.4% gain over the past four weeks.Elevance Health rallied for the sixth straight day, driven by optimism around its operations. The reaffirmed earnings forecast and medical enrollments boosted investor confidence, while multiple analyst updates with higher price targets added fuel to the momen ...

Group 1 - The article emphasizes a dividend-focused value investment strategy that prioritizes capital preservation and steady income growth [1] - The author discusses a diversified dividend stock portfolio that includes high-quality value stocks with potential for meaningful growth and long-term safety [1] Group 2 - The author has a beneficial long position in the shares of ELV, indicating a personal investment interest in the company [2] - The article is presented as a personal opinion and does not constitute professional investment or tax advice [3]

I only buy strong businesses. I only buy them when they're cheap. Backgrounds in economics, philosophy, government, data. I started my investing journey with a fairly concentrated portfolio of Canadian dividend payers in the telecom, pipeline and banking industries. I have moved forward through different industries including payments, US regional banking, Chinese and Brazilian equities, REITs, technology companies and a few other emerging market opportunities, as well as microcap through to megacap range. I ...

Revenue Sources - Approximately 31%, 29%, and 28% of total consolidated revenues were generated from U.S. government agencies for the years ended December 31, 2024, 2023, and 2022, respectively[24]. - The company’s Medicaid plans cover various state-sponsored programs and provided services in multiple states, including California, Florida, and Texas in 2024[37]. - The company anticipates growth in Public Exchange membership as former Medicaid members seek alternative coverage options, with plans to enter select service areas in Florida, Maryland, and Texas in 2025[31]. - The Consolidated Appropriations Act of 2023 has led to a decline in Medicaid membership, with expectations for growth in commercial plans as members seek alternative coverage[80]. - The Inflation Reduction Act of 2022 has extended enhanced Premium Tax Credits through 2025, supporting growth in Individual Public Exchange enrollment[81]. Health Services and Products - The Health Benefits segment offers a comprehensive suite of health plans and services, including risk-based and fee-based products, catering to various customer types such as Individual, Employer Group, Medicare, and Medicaid members[26]. - CarelonRx, the pharmacy services segment, includes a comprehensive portfolio of pharmacy services and recently expanded through the acquisition of Paragon Healthcare, Inc. in March 2024[26]. - Carelon Services aims to deliver whole health affordably by integrating physical, behavioral, pharmacy, and social services[41]. - Carelon Health provides value-based whole health solutions, managing home health and post-acute care costs, and has completed the acquisition of CareBridge to enhance virtual care for complex Medicaid and Medicare patients[42]. - The company’s product development emphasizes the unique needs of different customer types, aiming to provide value while achieving profitability[29]. Digital and Technological Advancements - The company continues to enhance customer interactions through digital technology, improving service quality and optimizing administrative costs[23]. - The digital engagement platform, Sydney Health, provides members with personalized health resources and virtual care services[66]. - Carelon's pricing strategy is based on predictive modeling and proprietary research, positioning the company for growth opportunities in new and existing markets[46]. Quality and Compliance - Carelon was awarded the NCQA 2023-2024 Innovation Award for advancements in maternal and neonatal outcomes, highlighting its commitment to quality healthcare[67]. - The company has incorporated several quality healthcare measures, including HEDIS, into its accreditation processes to improve care quality[68]. - Carelon Medical Benefits Management, Inc. aims to promote appropriate and affordable member care, focusing on areas such as maternity care and oncology drugs[68]. - The company has developed programs to address healthcare quality by identifying and closing care gaps, including a social determinants of health program[70]. - The company has implemented a "Food as Medicine" strategy to address food and nutrition insecurity among its members[71]. Financial Performance and Cash Flow - The net cash provided by operating activities decreased to $5,808 million in 2024 from $8,061 million in 2023, a decline of $2,253 million[353]. - Total sources of cash increased to $12,815 million in 2024, up from $8,839 million in 2023, reflecting a change of $3,976 million[353]. - The company issued $6,200 million in short- and long-term debt in 2024, a significant increase from $626 million in 2023[353]. - Cash dividends paid increased to $1,508 million in 2024 from $1,395 million in 2023, an increase of $113 million[353]. - The company reported a net increase in cash and cash equivalents of $1,828 million in 2024, compared to a decrease of $861 million in 2023[353]. Debt and Liquidity - The company's consolidated debt-to-capital ratio increased to 43.0% as of December 31, 2024, compared to 38.9% in 2023[360]. - Future debt and estimated interest payments total $52,073 million, with $2,855 million due within the next twelve months[376]. - The company has a common stock repurchase program authorized for up to $9,300 million, with no specified duration[374]. - The company has a senior revolving credit facility providing up to $4,000 million, maturing in April 2027, with a current debt-to-capital ratio of 43.0%[363]. - The company is in compliance with all debt covenants under its 5-Year Facility as of December 31, 2024[364]. Employee Engagement and Development - Employee population as of December 31, 2024, consisted of approximately 104,200 individuals, with 99% employed full-time[107]. - Company conducts annual internal associate engagement surveys to gather feedback and improve policies[111]. - Company achieved a pay equity analysis showing that pay for women is 99.2% of men and pay for people of color is 99.8% of white associates[113]. - In 2024, the company invested an average of approximately 27 hours of training and development per associate to enhance talent development and retention[114]. Market Competition - The managed care industry is highly competitive, with intense competition driven by aggressive marketing, pricing, and technological advancements[43]. - Carelon's provider networks offer competitive unit cost positions, allowing for a broad range of affordable health benefit products[47]. - The company employs a multi-year contracting strategy with providers to limit exposure to medical cost inflation and improve cost predictability[56]. - Carelon's medical management programs are designed to improve care quality and promote cost-effective medical care, administered by physicians and nurses[62]. Regulatory Environment - The company is subject to comprehensive state, federal, and international regulations that impact its operations and may lead to increased costs[76]. - The company’s insurance and HMO subsidiaries must comply with statutory risk-based capital requirements, which they have exceeded as of December 31, 2024[88]. - The ACA continues to introduce new risks and regulatory challenges that impact the company’s business model and strategy[89]. - The company is required to pay an annual license fee to the BCBSA based on enrollment and must comply with various operational requirements[73]. - Approximately 54.2% of premium revenue and 18.4% of medical membership were subject to minimum MLR regulations for the year ended December 31, 2024[90]. Medicare Advantage - 53% of Medicare Advantage members are enrolled in plans rated at least 4.0 Stars or higher, an increase from 34% in the original 2024 Star Rating[91]. - Expected reduction in 2026 operating revenue of approximately $183 million due to changes in Medicare Advantage Star Ratings[91]. - Anticipated growth in Public Exchange membership as former Medicaid members seek alternative coverage options[91]. - Company is entering select service areas in Florida, Maryland, and Texas in 2025, evaluating further expansion opportunities[91].

Elevance Health, Inc. (ELV) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% year over year.See the Zacks Earnings Calendar to stay ahead of market-making news.Operating revenues of $45 billion rose 6% year over year. Moreover, the top line beat the consensus mark by a whisker.Better-than-expected quarterly results benefited from rising premiums and product revenues. Rising expenses and ...

Financial Data and Key Metrics - The company will discuss its financial results and guidance for Q4 2024 and the outlook for 2025 [4] Business Line Data and Key Metrics - The company has multiple business lines including Government Health Benefits, Commercial Health Benefits, and Carelon, each led by respective presidents [3] Market Data and Key Metrics - No specific market data or key metrics mentioned in the provided content Company Strategy and Industry Competition - The CEO will review the progress made against the company's strategic initiatives and discuss the quarter and the 2025 outlook [4] Management Commentary on Operating Environment and Future Prospects - The CEO will provide insights into the company's strategic progress and future outlook during the call [4] Other Important Information - The conference call is being recorded, and participants are encouraged to present a single question during the Q&A session [2] Q&A Session Summary - No specific questions or answers were provided in the content for the Q&A session

Elevance Health 4Q 2024 Earnings Presentation January 23, 2025 The Value We Deliver We advance whole health through innovative solutions that integrate physical, behavioral, and social care to achieve our purpose of improving the health of humanity For Consumers Simple, Affordable, and Accessible Health Care For Care Providers Deepen Clinical and Business Partnerships 2 1. Simplifying healthcare through enhanced digital capabilities that personalize member experiences 2. Affordability at the core of our inn ...

Key TakeawaysElevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.Both earnings and revenue exceeded analysts' forecasts on what CEO Gail Boudreaux called "tangible progress in improving our operations."Elevance booted its quarterly dividend $0.08 to $1.71 per share. Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $44.67 billion, representing a surprise of +0.71%. The company delivered an EPS surprise of +1.05%, with the consensus EPS estimate being $3.80.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...